Seasonal Influenza Vaccination in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib
- PMID: 27533065
- PMCID: PMC6421570
- DOI: 10.1001/jamaoncol.2016.2437
Seasonal Influenza Vaccination in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib
Conflict of interest statement
Similar articles
-
Ibrutinib in Japanese patients with relapsed/refractory B-cell malignancies: final analysis of phase I study.Int J Hematol. 2019 Mar;109(3):366-368. doi: 10.1007/s12185-018-02577-8. Epub 2019 Jan 8. Int J Hematol. 2019. PMID: 30623356 Clinical Trial. No abstract available.
-
Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group.Haematologica. 2016 Dec;101(12):1573-1580. doi: 10.3324/haematol.2016.144576. Epub 2016 May 19. Haematologica. 2016. PMID: 27198718 Free PMC article.
-
Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial.Lancet Oncol. 2018 Jan;19(1):65-75. doi: 10.1016/S1470-2045(17)30909-9. Epub 2017 Dec 12. Lancet Oncol. 2018. PMID: 29246803 Free PMC article. Clinical Trial.
-
Adverse drug events associated with ibrutinib for the treatment of elderly patients with chronic lymphocytic leukemia: A systematic review and meta-analysis of randomized trials.Medicine (Baltimore). 2019 Aug;98(33):e16915. doi: 10.1097/MD.0000000000016915. Medicine (Baltimore). 2019. PMID: 31415440 Free PMC article.
-
How I manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemia.Blood. 2019 Mar 21;133(12):1298-1307. doi: 10.1182/blood-2018-11-846808. Epub 2019 Jan 14. Blood. 2019. PMID: 30642919 Free PMC article. Review.
Cited by
-
Management of infections for patient treated with ibrutinib in clinical practice.Front Oncol. 2024 Sep 10;14:1428464. doi: 10.3389/fonc.2024.1428464. eCollection 2024. Front Oncol. 2024. PMID: 39319061 Free PMC article. Review.
-
Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study.Cancers (Basel). 2021 Sep 6;13(17):4480. doi: 10.3390/cancers13174480. Cancers (Basel). 2021. PMID: 34503290 Free PMC article.
-
Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab.Clin Exp Med. 2023 Jun;23(2):371-379. doi: 10.1007/s10238-022-00809-0. Epub 2022 Mar 29. Clin Exp Med. 2023. PMID: 35352210 Free PMC article.
-
Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO).Ann Oncol. 2018 Jun 1;29(6):1354-1365. doi: 10.1093/annonc/mdy117. Ann Oncol. 2018. PMID: 29688266 Free PMC article. Review.
-
BTK Inhibitors in Chronic Lymphocytic Leukemia: Biological Activity and Immune Effects.Front Immunol. 2021 Jul 1;12:686768. doi: 10.3389/fimmu.2021.686768. eCollection 2021. Front Immunol. 2021. PMID: 34276674 Free PMC article. Review.
References
-
- Morrison VA. Infections in patients with leukemia and lymphoma. Cancer Treat Res 2014;161:319–349. - PubMed
-
- Centers for Disease Control and Prevention. Adult immunization schedule: United States, 2016 http://www.cdc.gov/vaccines/schedules/hcp/adult.html. Updated April 20, 2016. Accessed July 3, 2016.
-
- Whitaker JA, Shanafelt TD, Poland GA, Kay NE. Room for improvement: immunizations for patients with monoclonal B-cell lymphocytosis or chronic lymphocytic leukemia. Clin Adv Hematol Oncol 2014;12(7):440–450. - PubMed
-
- DiazGranados CA, Dunning AJ, Kimmel M, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 2014;371(7):635–645. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical